Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, Mind Medicine Inc’s stock clocked out at $13.58, down -0.44% from its previous closing price of $13.64. In other words, the price has decreased by -$0.44 from its previous closing price. On the day, 3.08 million shares were traded. MNMD stock price reached its highest trading level at $14.81 during the session, while it also had its lowest trading level at $13.318.
Ratios:
To gain a deeper understanding of MNMD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.30 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.31.
Upgrades & Downgrades
In the most recent recommendation for this company, Needham on October 13, 2025, initiated with a Buy rating and assigned the stock a target price of $28.
On January 28, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $23.Evercore ISI initiated its Outperform rating on January 28, 2025, with a $23 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 26 ’25 when Karlin Daniel sold 5,600 shares for $13.15 per share. The transaction valued at 73,623 led to the insider holds 425,025 shares of the business.
Barrow Robert sold 25,791 shares of MNMD for $339,072 on Dec 26 ’25. The Chief Executive Officer now owns 778,477 shares after completing the transaction at $13.15 per share. On Dec 26 ’25, another insider, Sullivan Mark, who serves as the Chief Legal Officer of the company, sold 11,276 shares for $13.15 each. As a result, the insider received 148,244 and left with 282,576 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 1320236672 and an Enterprise Value of 1169671040.
Stock Price History:
The Beta on a monthly basis for MNMD is 2.62, which has changed by 0.6818743 over the last 52 weeks, in comparison to a change of 0.16067612 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $14.43, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is 9.61%, while the 200-Day Moving Average is calculated to be 44.78%.
Shares Statistics:
It appears that MNMD traded 1.94M shares on average per day over the past three months and 2345130 shares per day over the past ten days. A total of 76.77M shares are outstanding, with a floating share count of 73.44M. Insiders hold about 2.80% of the company’s shares, while institutions hold 51.96% stake in the company. Shares short for MNMD as of 1765756800 were 12612667 with a Short Ratio of 6.49, compared to 1763078400 on 12287817. Therefore, it implies a Short% of Shares Outstanding of 12612667 and a Short% of Float of 12.879999999999999.
Earnings Estimates
At present, 9.0 analysts are actively evaluating the performance of Mind Medicine Inc (MNMD) in the stock market.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.43 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.7 and -$2.31 for the fiscal current year, implying an average EPS of -$2.02. EPS for the following year is -$1.77, with 10.0 analysts recommending between -$1.0 and -$2.08.
